Stocks
Johnson & Johnson Financial Statements (JNJ) |
||||||||||
| Johnson & Johnsonsmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 22.02.2021 | 17.02.2022 | 31.12.2022 | 16.02.2023 | 16.02.2024 | 01.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 82 584 | 93 775 | 94 943 | 94 943 | 85 152 | 85 501 | |||
| Operating Income, bln rub | 19 824 | 24 417 | 23 703 | 23 917 | 21 853 | 22 087 | ||||
| EBITDA, bln rub | ? | 20 342 | 25 699 | 21 939 | 24 024 | 29 339 | 29 435 | |||
| Net profit, bln rub | ? | 14 714 | 20 878 | 17 941 | 17 941 | 35 153 | 38 686 | |||
| OCF, bln rub | ? | 23 536 | 23 410 | 21 194 | 21 194 | 22 791 | 19 009 | |||
| CAPEX, bln rub | ? | 3 347 | 3 652 | 4 009 | 4 009 | 4 543 | 3 363 | |||
| FCF, bln rub | ? | 20 189 | 19 758 | 17 185 | 17 185 | 18 248 | 15 646 | |||
| Dividend payout, bln rub | 10 481 | 11 032 | 11 682 | 11 682 | 11 770 | 8 605 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 71.2% | 52.8% | 65.1% | 65.1% | 33.5% | 22.2% | ||||
| OPEX, bln rub | 34 243 | 39 373 | 40 151 | 40 151 | 36 560 | 37 805 | ||||
| Cost of production, bln rub | 28 427 | 29 855 | 31 089 | 31 089 | 26 739 | 25 609 | ||||
| R&D, bln rub | 12 159 | 14 714 | 15 386 | 15 386 | 15 048 | 15 003 | ||||
| Interest expenses, bln rub | 201.0 | 183.0 | 214.0 | 276.0 | 1 247 | 654.0 | ||||
| Assets, bln rub | 174 894 | 182 018 | 187 378 | 187 378 | 167 558 | 171 966 | ||||
| Net Assets, bln rub | ? | 63 278 | 74 023 | 76 804 | 76 804 | 68 774 | 70 020 | |||
| Debt, bln rub | 35 266 | 33 751 | 39 659 | 39 659 | 30 432 | 33 632 | ||||
| Cash, bln rub | 25 185 | 31 608 | 23 519 | 23 519 | 22 927 | 26 218 | ||||
| Net debt, bln rub | 10 081 | 2 143 | 16 140 | 16 140 | 7 505 | 7 414 | ||||
| Ordinary share price, rub | 157.4 | 171.1 | 176.7 | 176.7 | 156.7 | 150.2 | ||||
| Number of ordinary shares, mln | 2 633 | 2 632 | 2 632 | 2 625 | 2 407 | 2 408 | ||||
| Market cap, bln rub | 414 350 | 450 273 | 464 960 | 463 742 | 377 285 | 361 736 | ||||
| EV, bln rub | ? | 424 431 | 452 416 | 481 100 | 479 882 | 384 790 | 369 150 | |||
| Book value, bln rub | -26 517 | -7 615 | -16 752 | -16 752 | -1 959 | -882 | ||||
| EPS, rub | ? | 5.59 | 7.93 | 6.82 | 6.83 | 14.6 | 16.1 | |||
| FCF/share, rub | 7.67 | 7.51 | 6.53 | 6.55 | 7.58 | 6.50 | ||||
| BV/share, rub | -10.1 | -2.89 | -6.36 | -6.38 | -0.81 | -0.37 | ||||
| EBITDA margin, % | ? | 24.6% | 27.4% | 23.1% | 25.3% | 34.5% | 34.4% | |||
| Net margin, % | ? | 17.8% | 22.3% | 18.9% | 18.9% | 41.3% | 45.2% | |||
| FCF yield, % | ? | 4.87% | 4.39% | 3.70% | 3.71% | 4.84% | 4.33% | |||
| ROE, % | ? | 23.3% | 28.2% | 23.4% | 23.4% | 51.1% | 55.2% | |||
| ROA, % | ? | 8.41% | 11.5% | 9.57% | 9.57% | 21.0% | 22.5% | |||
| P/E | ? | 28.2 | 21.6 | 25.9 | 25.8 | 10.7 | 9.35 | |||
| P/FCF | 20.5 | 22.8 | 27.1 | 27.0 | 20.7 | 23.1 | ||||
| P/S | ? | 5.02 | 4.80 | 4.90 | 4.88 | 4.43 | 4.23 | |||
| P/BV | ? | -15.6 | -59.1 | -27.8 | -27.7 | -192.6 | -410.1 | |||
| EV/EBITDA | ? | 20.9 | 17.6 | 21.9 | 20.0 | 13.1 | 12.5 | |||
| Debt/EBITDA | 0.50 | 0.08 | 0.74 | 0.67 | 0.26 | 0.25 | ||||
| R&D/CAPEX, % | 363.3% | 402.9% | 383.8% | 383.8% | 331.2% | 446.1% | ||||
| CAPEX/Revenue, % | 4.05% | 3.89% | 4.22% | 4.22% | 5.34% | 3.93% | ||||
| Johnson & Johnson shareholders | ||||||||||
